InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
ITO | Ann: Removal from Official List | 10:41 | 0 | 607 | |||
|
|||||||
ITO | Ann: Ceasing to be a substantial holder | 16/12/10 | 0 | 377 | |||
|
|||||||
ITO | Ann: Change in substantial holding | 16/12/10 | 0 | 399 | |||
|
|||||||
ITO | Ann: Appendix 3Z - Final Directors Interest Notic | 14/12/10 | 0 | 330 | |||
|
|||||||
ITO | Ann: Resignation and Appointment of Intoll Direct | 14/12/10 | 0 | 427 | |||
|
|||||||
ITO +NAB | Ann: Ceasing to be a substantial holder from NAB | 10/12/10 | 0 | 361 | |||
|
|||||||
ITO +NAB | Ann: Change in substantial holding from NAB | 09/12/10 | 0 | 301 | |||
|
|||||||
ITO | Ann: Change in substantial holding | 03/12/10 | 0 | 253 | |||
|
See All Discussions